Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Kathleen Tregoning is on the board of Spero Therapeutics, Inc. and Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc.

In the past she held the position of Executive Vice President-External Affairs at Sanofi and Senior Vice President-Corporate Affairs at Biogen France SAS.

Ms. Tregoning received an undergraduate degree from Stanford University and a graduate degree from Harvard Kennedy School of Government.


Current positions of Kathleen Tregoning 
NameTitle Since
Spero Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Cerevel Therapeutics Holdings, Inc.
(Biotechnology & Medical Research)
Chief Corporate Affairs Officer 2020


Kathleen Tregoning: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Kathleen Tregoning : Connections